News

AltheaDx Prospective, Randomized Controlled Clinical Trial Demonstrates Significant Improvements in the Treatment of Depression and Anxiety over Standard of Care

September 26, 2017 by altheadx

SAN DIEGO, Sept. 26, 2017 /PRNewswire/ — AltheaDx, Inc. (“AltheaDx” or the “Company”), a commercial stage molecular diagnostics company specializing in the field of personalized medicine, announced today that the results from its clinical trial have been accepted for publication… Read the rest

AltheaDx Closes $27 Million Series D Financing

May 15, 2017 by altheadx

San Diego, California – April 25, 2017 – AltheaDx, Inc. (“AltheaDx” or the “Company”), a commercial stage molecular diagnostics company specializing in the field of personalized medicine, today announced that it has raised $27 million in its Series D funding.… Read the rest

AltheaDx Announces Appointment of Chief Financial Officer

October 21, 2016 by altheadx

San Diego, California – October 17, 2016 – AltheaDx, Inc. (“AltheaDx” or the “Company”), a commercial stage molecular diagnostics company specializing in the field of personalized medicine, today announced the appointment of Mr. Andrew Jackson as Chief Financial Officer. Mr.… Read the rest